NCT06209333
Effect of BT and PFET on Urinary Symptoms and Quality of Life in Patients With OABS No drug interventions treatment Not Available recruiting NCT00409539
SMP-986 Phase 2 Proof of Concept in Patients With Overactive Bladder Syndrome (OABS) No drug interventions treatment 2 completed NCT01777217
VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the Prostate treatment 4 terminated NCT04914221
The Safety and PK Characteristics of the Co-administration of JLP-2002 and Comparator in Healthy Volunteers No drug interventions treatment 1 completed NCT01500382
A Study of the Pharmacokinetics and Pharmacodynamics of Vibegron (MK-4618) in Women With Overactive Bladder (MK-4618-004) treatment 1 terminated NCT00850733
516-BOTOX Urinary Incontinence Detrusor No drug interventions Not Available Not Available completed NCT03697954
Direct Full-stage Implantation of Sacral Neuromodulation No drug interventions Not Available Not Available withdrawn NCT02673047
Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive Bladder Not Available Not Available completed NCT01750645
Management of the Idiopathic Overactive Bladder With Botulinum Toxin: Systematic Review No drug interventions Not Available Not Available unknown_status NCT02087098
A Study to Evaluate Quality of Life in Patients Switched to Solifenacin From Other Antimuscarinics Not Available Not Available completed NCT03560778
Comparisons of Urodynamic, Bladder Diary, Quality of Life Parameters Between OAB-wet and OAB-dry Female Patients No drug interventions Not Available Not Available completed NCT03681678
Laser Therapy for Treatment of Urogenital Symptoms in Women No drug interventions Not Available Not Available active_not_recruiting NCT02010788
Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korea Not Available Not Available completed NCT06390488
Transcutaneous Medial Plantar Nerve Stimulation in Women With Idiopathic Overactive Bladder No drug interventions other Not Available not_yet_recruiting NCT00688688
Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder treatment 3 completed NCT02505607
Overactive Bladder Education No drug interventions supportive_care Not Available terminated NCT02992509
IVES for Treatment of UUI and OAB No drug interventions treatment 0 completed NCT01558856
Unilateral Versus Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder No drug interventions treatment Not Available completed NCT05668715
Transcutaneous Tibial Nerve Stimulation in Antimuscarinic Naive and Refractory Women With Idiopathic Overactive Bladder No drug interventions treatment Not Available not_yet_recruiting NCT02462837
Myrbetriq™ (Mirabegron) to Reduce Pain and Discomfort Following Ureteral Stent Placement treatment 2 terminated NCT03874637
FemPulse Therapy First-in-Human Experience No drug interventions other Not Available completed NCT01638000
A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment. treatment 3 completed NCT03784170
FemPulse Therapy for Overactive Bladder in Women No drug interventions treatment Not Available unknown_status NCT00368706
A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients treatment 3 completed NCT00699049
A Study Comparing the Efficacy of an Alpha Blocker Versus an Alpha Blocker Plus Solifenacin in Men With Overactive Bladder treatment 4 completed NCT06201013
Efficacy and Safety of Vitamin D in the Treatment of OAB-wet in Children treatment Not Available recruiting NCT01091519
Non-Interventional Study To Investigate Whether Information Provided To Patients Influences Their Satisfaction With Toviaz Therapy No drug interventions Not Available Not Available terminated NCT00463541
Open-label Study of the Efficacy and Safety of VESIcare® in Patients With Overactive Bladder Symptoms treatment 3 completed NCT00798434
A Study to Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder. treatment 4 completed NCT03807024
Age-specific Prevalence and Comparisons of UDS and Bladder Diary Between OAB-wet and -Dry Women No drug interventions Not Available Not Available completed NCT01054222
Local, Open-Label, Extension Trial Of The Efficacy And Safety Of Fesoterodine In Elderly Patients With Overactive Bladder treatment 4 completed NCT02045862
A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder treatment 3 completed NCT01908829
A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin) treatment 3 completed NCT03519126
Electrostimulation in the Treatment of Idiopathic Overactive Bladder No drug interventions treatment Not Available terminated NCT03520166
Use of Medium Frequency Electrotherapy in the Treatment of OAB, LUTS and Pelvic Pain No drug interventions treatment Not Available completed NCT06162065
Effectiveness of Oral Boldo in Women With Overactive Bladder treatment 1 enrolling_by_invitation NCT01340027
A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder treatment 2 completed NCT00613327
An Efficacy and Safety Study of Oxybutynin Chloride Oral Osmotic Therapeutic System (OROS) in Korean Overactive Bladder Participants treatment 4 completed NCT01566760
A Study To Estimate The Effects Of Food On Drug Fesoterodine Fumarate And The Pharmacokinetics Of 5-Hydroxymethyl Tolterodine (5-HMT) In Healthy Volunteers basic_science 1 completed NCT03523091
OnabotulinumtoxinA Bladder Injection Study treatment 4 terminated NCT01262391
Single-dose Study to Assess Pharmacokinetics of Solifenacin Succinate Suspension in Children and Adolescents treatment 1 completed NCT05880862
Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls treatment 0 recruiting NCT00646880
A Study to Evaluate the Efficacy of Tolterodine Prolonged Release Compared With Propiverine for the Treatment of Korean Patients With Overactive Bladder as Assessed by Ambulatory Urodynamic Monitoring treatment 3 completed NCT00801944
Solifenacin Succinate 5mg or 10mg Once Daily in the Treatment of Urgency Symptoms treatment 3 completed NCT00914667
The Effect Of Fesoterodine On Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects treatment 1 completed NCT01521767
Pharmacokinetics and Relative Bioavailability Study other 1 completed NCT06336304
NXT Post-Market Clinical Follow-up No drug interventions Not Available Not Available recruiting NCT01314872
A Study of the Efficacy and Safety of Vibegron (MK-4618) in Participants With Overactive Bladder (OAB) (MK-4618-008) treatment 2 completed NCT00971646
Cohort Study: Perceptual Urge Sensation No drug interventions Not Available Not Available completed NCT00645281
A Study to Evaluate the Efficacy of Tolterodine on Specific Symptoms in Adult Patients With Overactive Bladder. treatment 4 completed NCT05250908
INTIBIA Pivotal Study No drug interventions treatment Not Available recruiting NCT00573508
Study of VESIcare® In Overactive Bladder (OAB) Subjects to Evaluate Symptom Bother and Health Related Quality of Life treatment 4 completed NCT00912964
A Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder treatment 3 completed NCT03052764
Evaluation of an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary Incontinence treatment 4 completed NCT04528784
Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis No drug interventions treatment Not Available completed NCT00805779
Pulsed Electromagnetic Stimulation for Treatment of Overactive Bladder No drug interventions treatment Not Available terminated NCT00985387
Evaluation of Adherence to Solifenacin Treatment in Overactive Bladder Patients Not Available Not Available completed NCT03043287
Voiding Efficiency, a Predictor of Clean Intermittent Catheterization (CIC) Not Available Not Available completed NCT04420533
Comparative Study Between Behavior Therapy and Behavior Therapy Plus Mirabegron in Sexually Active Men With OAB Symptoms treatment Not Available completed NCT00527033
A Study of YM178 in Patients With Symptomatic Overactive Bladder treatment 2 completed NCT01302054
A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine. treatment 4 completed NCT06210477
Association With Low Compliance Bladder in Women With LUTS No drug interventions Not Available Not Available not_yet_recruiting NCT01157377
Safety and Efficacy Study of AGN-214868 in Patients With Idiopathic Overactive Bladder and Urinary Incontinence treatment 2 completed NCT00840645
A Long-term Study of YM178 in Symptomatic Overactive Bladder Patients treatment 3 completed NCT00675298
Linkage Analysis in Interstitial Cystitis No drug interventions Not Available Not Available completed NCT00479505
Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive Bladder treatment 2 completed NCT01604928
Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder treatment 2 completed NCT05328011
Targeting Microbiota in Female Overactive Bladder Syndrome No drug interventions Not Available Not Available recruiting NCT05309993
INvestigation of TENS Efficacy Versus Posterior Tibial Nerve Stimulation for Overactive Bladder No drug interventions treatment Not Available recruiting NCT02557971
Urinary Retention Rates in Clinical Practice After Treatment With OnabotulinumtoxinA for Idiopathic Overactive Bladder Not Available Not Available completed NCT01565707
A Study to Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug treatment 3 completed NCT00662909
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder treatment 3 completed NCT00795509
Special Investigation For Long Term Use Of Tolterodine (Regulatory Post Marketing Commitment Plan). Not Available Not Available completed NCT05968885
Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity treatment 4 recruiting NCT01922115
The Effect of Anticholinergics on Cognitive Function in the Elderly basic_science 4 completed NCT01595152
Solifenacin Succinate Versus Fesoterodine A Comparison Trial for Urgency Symptoms treatment Not Available unknown_status NCT02385500
Fesoterodine on Urgency Episodes in Parkinson's Disease Population treatment 4 terminated NCT02161159
An Observational Study of BOTOX® for the Management of Urinary Incontinence in Patients With Idiopathic Overactive Bladder Not Available Not Available completed NCT01194999
Evaluating the Change of Overactive Bladder Symptoms in Women Post Pubovaginal Sling Procedure for Stress Incontinence No drug interventions treatment 4 completed NCT00814736
A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031 basic_science 1 completed NCT02386072
A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB) Not Available Not Available completed NCT02320773
A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice Not Available Not Available completed NCT01972841
This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder treatment 3 completed NCT02849418
Efficacy and Safety Study of GSK1358820 in Japanese Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity No drug interventions treatment 3 completed NCT02456441
Effects of TENS in Autonomous System in Women With Overactive Bladder No drug interventions treatment Not Available unknown_status NCT02477241
Brain Areas Involved in Bladder Filling and Contraction No drug interventions diagnostic Not Available unknown_status NCT00454896
A Multicenter VESIcare® Efficacy and Safety Study for the Treatment of Urgency Associated With Overactive Bladder (OAB) treatment 3 completed NCT04001426
Pilot Phase for an Acute Evaluation of a Non-Implantable Electrical Continence Device No drug interventions device_feasibility Not Available completed NCT01043666
A Study of YM178 in Subjects With Symptoms of Overactive Bladder treatment 3 completed NCT06479720
Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder treatment 4 recruiting NCT04807920
BOTOX® at the Time of Prolapse Surgery for OAB treatment 4 unknown_status NCT01381120
Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms treatment 4 completed NCT00802373
Solifenacin Succinate Versus Tolterodine 4mg Once Daily treatment 3 completed NCT06349694
Comparison of the Efficacy of Transcutaneos Nerve Stimulations in Women With Idiopathic Overactive Bladder No drug interventions other Not Available not_yet_recruiting NCT00806494
UK Study Assessing Flexible Dose Fesoterodine in Adults treatment 4 completed NCT02742389
Urodynamic Testing: Can we Improve Patient Experience? No drug interventions other Not Available completed NCT03625492
Fluids Affecting Bladder Urgency and Lower Urinary Symptoms No drug interventions treatment Not Available completed NCT02820844
Efficacy and Safety of GSK1358820 in Subjects With Overactive Bladder No drug interventions treatment 3 completed NCT00454740
Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive Bladder treatment 3 completed NCT00966004
A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder treatment 3 completed NCT00689104
Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder treatment 3 completed NCT00979472
Solifenacin Flexible Dosing Study in Frequent Micturition Patients With and Without Urgency treatment 4 completed NCT05715268
Wearables for the Bladder: an In-home Treatment Feasibility Pilot Study No drug interventions treatment Not Available recruiting NCT06385769
Transcutaneous Tibial Nerve Stimulation in Patients With Neurogenic Overactive Bladder After Stroke No drug interventions other Not Available not_yet_recruiting NCT01655069
A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076 treatment 3 completed NCT02701010
Behavioural Therapy Program for Female Overactive Bladder No drug interventions treatment Not Available completed NCT06197295
Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity treatment 4 recruiting NCT00928395
Modified Extension Study to the SUmiT Trial: Evaluation of Long Term Therapy With Percutaneous Tibial Nerve Stimulation (PTNS) for Overactive Bladder Symptoms No drug interventions treatment 4 completed NCT01540214
Study of Overactive Bladder in Women With Prolapse No drug interventions Not Available Not Available unknown_status NCT05416450
The Efficacy of Intravaginal Electrical Stimulation in Women With Idiopathic Overactive Bladder No drug interventions treatment Not Available recruiting NCT01698138
Prevention of Bladder Dysfunction in Acute Spinal Cord Injury treatment 4 completed NCT04305743
Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A treatment 4 recruiting NCT03238053
Laser Treatment of Genito-urinary Syndrome in Women No drug interventions supportive_care Not Available not_yet_recruiting NCT04160793
Genital Nerve Stimulation - GNS - for Treatment of Non-neurogenic OAB No drug interventions treatment Not Available unknown_status NCT05463822
Transvaginal Botulinum Toxin A Chemodenervation for Overactive Bladder treatment 0 completed NCT05106504
Effect of Medical Cannabis for Non-motor Symptoms of Parkinson's Disease Not Available Not Available unknown_status NCT04075578
Evaluation of Professional Practices in the Treatment of Refractory Idiopathic Overactive Bladder at the Dose of 50 Units (TOX50IUU) Not Available Not Available unknown_status NCT06508944
Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women treatment 4 active_not_recruiting NCT03817203
Effects of Kinesio Taping Application in Women With Overactive Bladder No drug interventions treatment Not Available unknown_status NCT05221021
Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome treatment 4 recruiting NCT04023253
Pharmacologic Effect for Female Overactive Bladder Syndrome: Mirabegron Versus Solifenacin treatment 3 recruiting NCT01884753
Correlations of 3D Urethral and Paraurethral Sonographic Findings With Urodynamic Studies, Lower Urinary Tract Symptoms & Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms. No drug interventions Not Available Not Available completed NCT05250245
Tolterodine Relieves Overactive Bladder Symptoms in Women With Moderate-to-severe Obstructive Sleep Apnea Syndrome treatment 4 completed NCT05895045
Yoga for Treatment of Overactive Bladder in Pediatric Patients No drug interventions treatment Not Available recruiting NCT06283498
Transvaginal Detrusor Nerve Radiofrequency Ablation for Treatment of Overactive Bladder No drug interventions treatment Not Available enrolling_by_invitation NCT06024005
Comparison of the Transcutaneous Tibial Nerve Stimulation and Drug Treatment' Effects in Women With Overactive Bladder treatment Not Available completed NCT04693897
Effect of beta3-adrenoceptor Agonist on Patients With Overactive Bladder and as a Urinary Biomarker Not Available Not Available unknown_status NCT06143397
Effect of TTNS and PNS on Neurogenic Overactive Bladder Symptoms in Female Patients With Multiple Sclerosis. No drug interventions treatment Not Available recruiting NCT06212661
Migraine Medication Effects on Urinary Symptoms Not Available Not Available enrolling_by_invitation NCT06045728
Telerehabilitation for Overactive Bladder Syndrome in Obese Women No drug interventions treatment Not Available recruiting NCT00909428
Validation of a Real-time Urodynamic Measure of Urinary Urgency treatment 4 completed NCT06034288
Xeomin vs Botox for Treatment of Overactive Bladder Syndrome treatment 2 recruiting NCT01912885
Comparison of Posterior Tibial Nerve Electrical Stimulation Protocols for Overactive Bladder Syndrome No drug interventions treatment Not Available completed NCT00546637
Fesoterodine "add-on" Male Overactive Bladder Study treatment 3 completed NCT04873037
BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder No drug interventions treatment Not Available recruiting NCT03251300
Mirabegron for Female OAB Patients: Comparison of Daytime and Nighttime Dosing treatment 4 recruiting NCT06024642
Study of V117957 in Overactive Bladder Syndrome treatment 1 completed NCT03952299
Oxybutynin for Post-surgical Bladder Pain and Urgency treatment 3 recruiting NCT05572918
Developing a Simple Test to Diagnose Overactive Bladder No drug interventions Not Available Not Available not_yet_recruiting NCT00982241
Overactive Bladder (OAB) Drink Advice Study No drug interventions supportive_care Not Available withdrawn NCT05977634
Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder No drug interventions treatment Not Available not_yet_recruiting NCT03516435
Efficacy of Different Electrical Stimulation Placement in Patients With Overactive Bladder Syndrome No drug interventions treatment Not Available unknown_status NCT00220363
A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder Syndrome Not Available 3 completed NCT01876186
Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB Patients treatment 4 unknown_status NCT03486639
Urodynamics and Clinical Factors That Are Associated With Bladder Over-sensitivity No drug interventions Not Available Not Available unknown_status NCT06198439
rTMS in Overactive Bladder No drug interventions other Not Available recruiting NCT05493748
Virtual Bladder Training for Overactive Bladder Syndrome in Women. Which Symptom Responds Better? No drug interventions treatment Not Available unknown_status NCT06540248
Real-life Clinical Experience With Ialuadapter Study No drug interventions Not Available Not Available completed NCT05543382
Cycling Study With the Axonics System No drug interventions Not Available Not Available active_not_recruiting NCT00220376
Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder Syndrome treatment 3 completed NCT06088394
Effect of Acupuncture Augmented With Pelvic Floor Exercises on Overactive Bladder No drug interventions treatment Not Available recruiting NCT01164280
Effect of Pulse Rate Changes on Clinical Outcome No drug interventions treatment Not Available completed NCT03755089
Oral vs Intravesical Analgesia for Office Bladder Botox Injections treatment 4 unknown_status NCT03750604
Central Obesity in Cases of OAB No drug interventions diagnostic Not Available completed NCT03632772
Comparison of Solifenacin and Mirabegron in Treatment of Overactive Bladder Symptoms in Men After TURP treatment 2 unknown_status NCT01819168
Antimuscarinic Treatment for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing No drug interventions Not Available Not Available completed NCT00839969
Cystoscopy Plus Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding No drug interventions treatment Not Available unknown_status NCT01114412
Basic Sensations Coming From the Bladder No drug interventions Not Available Not Available completed NCT00912314
Trial of Maintenance Therapy With Posterior Tibial Nerve Stimulation for Overactive Bladder No drug interventions treatment Not Available completed NCT04909255
Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder treatment 4 unknown_status NCT00170755
A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder treatment 3 completed NCT03250650
Physiotherapy in Overactive Bladder: Electrical Stimulation Treatment No drug interventions treatment Not Available completed NCT01559623
Colonization of the Female Urethra With Mycoplasma Hominis, Ureaplasma Urealyticum, Chlamydia Trachomatis, or Neisseria Gonorrhea in Patients With Lower Urinary Tract Symptoms No drug interventions Not Available Not Available completed NCT06389838
RCT on Multimodal Self-treatment for Women With Incontinence Using a Digital Health Application No drug interventions treatment Not Available recruiting NCT06094543
Improving Overactive Bladder Treatment Access and Adherence No drug interventions treatment Not Available not_yet_recruiting NCT06123364
Extracorporeal Magnetic Innervation in Combination With Mirabegron in the Treatment of Overactive Bladder treatment Not Available completed NCT00220402
Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome Not Available 3 completed NCT05313984
OptiLUTS Part C: The Development of a Symptom Assessment Tool in Sacral Neuromodulation. No drug interventions Not Available Not Available completed NCT05040984
Predictors Affecting Long-term Use of Solifenacin or Mirabegron in Women With Overactive Bladder Syndrome Not Available Not Available recruiting NCT05308979
Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial treatment 4 completed NCT05878951
Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms treatment 2 / 3 recruiting NCT01627145
Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug treatment Not Available unknown_status NCT02024945
Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder Syndrome Not Available Not Available completed NCT00171145
A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overactive Bladder. treatment 3 completed NCT04599283
BE Technologies Mobile Uroflowmetry Validation Study No drug interventions diagnostic Not Available completed NCT06351683
Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome treatment 2 recruiting NCT06438861
Role of Combination Therapy in Women With Refractory Overactive Bladder treatment Not Available not_yet_recruiting NCT02540707
Comparisons of the Effects of Solifenacin Versus Mirabegron on Autonomic System, Arterial Stiffness and Psychosomatic Distress and Clinical Outcomes treatment 4 completed NCT05792956
Mobile Application and Bladder Training No drug interventions supportive_care Not Available enrolling_by_invitation NCT05719285
Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection No drug interventions prevention 4 completed NCT00628615
Non-Micturation Bladder Activity in Relation to Self-Consciousness During Filling Phase and Sensation Measurement During the Filling Phase No drug interventions Not Available Not Available unknown_status NCT04300400
Treatment of the Overactive Bladder Syndrome: A Delphi Study No drug interventions Not Available Not Available completed NCT05188742
Sequencing and Combination of Mirabegron and TTNS in Overactive Bladder Syndrome: a Multicenter, Randomized, Open-label, Crossover Trial treatment 4 unknown_status NCT02854813
Overactive Bladder in Elderly Patients- An Early Warning of Coronary Artery Disease No drug interventions Not Available Not Available completed NCT01042119
Intravesical Injection of Botox for Treating Therapy Refractory Overactive Bladder in Females No drug interventions Not Available Not Available completed NCT04483817
Efficacy of Transcutaneous Versus Percutaneous Posterior Tibial Nerve Stimulation in the Overactive Bladder. No drug interventions treatment Not Available unknown_status NCT06080217
RF in the Treatment OAB in UUI- a Prospective Randomized Placebo Controlled Study No drug interventions treatment Not Available active_not_recruiting NCT03059134
Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan treatment 3 completed NCT03758235
Overactive Bladder Syndrome: Incobotulinumtoxin Versus Onabotulinumtoxin treatment 3 unknown_status NCT03695822
Impact of Beta-3 Agonist on Psychological Distress and Blood Flow of the Bladder in Women With Overactive Bladder Syndrome treatment 4 withdrawn NCT03322748
Efficacy of Lower Limb Exercises on Overactive Bladder Symptoms in Patients With Multiple Sclerosis No drug interventions treatment Not Available unknown_status NCT03535857
Effectiveness of Bilateral PTNS Compared to Unilateral PTNS for the Treatment of Overactive Bladder/Urge Incontinence No drug interventions treatment Not Available recruiting NCT04270526
Minimizing Pain During Office Intradetrussor Botox Injection No drug interventions treatment 4 completed NCT04197466
Comparison of Different Treatments for Overactive Bladder Syndrome No drug interventions treatment Not Available completed NCT04982120
Use of Repris Needle in Bladder Injection No drug interventions treatment Not Available unknown_status NCT06341673
Impact of TTNS on Bladder Symptoms Among People With MS, A RCT No drug interventions treatment Not Available recruiting NCT05069376
Effect of Ureteral Stents Length and Location on Related Symptom No drug interventions prevention Not Available completed NCT04256876
TTNS Versus Sham Therapy for Children With iOAB (TaPaS Part I) No drug interventions treatment Not Available terminated NCT00335660
Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity treatment 2 terminated NCT03536494
Effectiveness of a Structured Intervention to Optimize the Use of Mirabegron No drug interventions health_services_research Not Available completed NCT03435991
Experience Sampling Method in OAB Patients No drug interventions Not Available Not Available unknown_status NCT03533062
Trigonal vs Non Trigonal Botox Injection in OAB. treatment Not Available completed NCT06546189
Oral Lactobacillus Supplementation as Treatment for Overactive Bladder Syndrome: A Randomised Controlled Trial No drug interventions treatment Not Available not_yet_recruiting NCT03532789
Herbal Patch for Overactive Bladder No drug interventions treatment 2 / 3 completed NCT03559946
Condensed Percutaneous Tibial Nerve Stimulation (PTNS) Protocol No drug interventions treatment Not Available terminated NCT03044912
Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan treatment 3 unknown_status NCT03331081
Effects of Bladder Training and Pelvic Floor Muscle Training on the Symptomatology of Overactive Bladder Syndrome No drug interventions treatment Not Available unknown_status NCT05151081
Overactive Bladder Syndrome No drug interventions Not Available Not Available completed NCT05157295
Comparing Number of Injection Sites of In-office Intravesical Onabotulinumtoxin A Treatments for Overactive Bladder: A Randomized Controlled Trial treatment 4 unknown_status NCT00821314
The Effect of Position on Urge Sensation in Volunteers and in Patients With Overactive Bladder Syndrome No drug interventions Not Available Not Available unknown_status NCT05094414
Using Oral Valacyclovir to Treat Patients With Refractory IC/BPS treatment 1 unknown_status NCT04858750
Comparison and Evaluation of USSQ, OABSS, and the Drainage/Anti-reflux Effect Between Three Kinds of Ureteral D-J Stents in Patients Who Underwent URL No drug interventions treatment Not Available unknown_status NCT06170450
Cyclic Versus Continuous Sacral Neuromodulation for LUTS No drug interventions treatment Not Available recruiting NCT02138747
A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB) treatment 4 completed NCT05211193
Open Label Study to Evaluate the Efficacy of the Home Based Electrical Transcutaneous URIS I in the Treatment of Overactive Bladder (OAB). No drug interventions Not Available Not Available completed NCT00282932
Detrol LA In Men With Overactive Bladder. treatment 4 completed NCT01936870
Drug Use Investigation for Toviaz Not Available Not Available completed NCT02294396
Postmarketing Study to Evaluate add-on Therapy With Anticholinergics in Patients With Overactive Bladder (OAB) on Mirabegron. treatment 4 completed NCT04451382
PTNS vs Botox of Refractory OAB Not Available Not Available terminated NCT03572231
A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China Not Available Not Available completed NCT03903094
A Study on Anticholinergic Use: Attribution of Overactive Bladder (OAB) Medications to the Anticholinergic Burden No drug interventions Not Available Not Available completed NCT01639794
Vesitirim™ in Men Postmarketing Observational Study Not Available Not Available completed NCT00507169
SVT-40776 in Patients Suffering From Overactive Bladder Syndrome No drug interventions treatment 2 completed NCT01317810
A Study Measuring and Tracking Changes in Overactive Bladder (OAB) Medication No drug interventions Not Available Not Available withdrawn NCT03846895
Vaginal CO2 Laser in Postmenopausal Women With Overactive Bladder Syndrome (OAB) No drug interventions treatment Not Available completed NCT04562090
A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladder treatment 4 completed NCT00366002
Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder treatment 4 completed NCT00742833
A Phase II Study of KUC-7483 in Patients With Overactive Bladder treatment 2 completed NCT04641975
A Study to Evaluate Mirabegron in Pediatric Participants From 5 to Less Than 18 Years of Age With Overactive Bladder (OAB) treatment 3 terminated NCT02216214
Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB) treatment 4 completed NCT03602508
Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania Not Available Not Available completed NCT06072703
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS No drug interventions treatment Not Available recruiting NCT05798403
Efficacy of Electroacupuncture Versus Solifenacin Succinate for Female Overactive Bladder treatment Not Available recruiting NCT05709990
Efficacy and Safety of High Dose Vitamin D Supplementation for Overactive Bladder Dry in Children treatment Not Available completed NCT00282490
Surface Nerve Stimulation Treatment for OAB in Children No drug interventions treatment Not Available completed NCT04309890
Arabic Translation and Validation of the (Overactive Bladder Symptom Score) OABSS No drug interventions Not Available Not Available completed NCT04936464
Transcutaneous Tibial Nerve Stimulation for Urgency Urinary Incontinence No drug interventions treatment Not Available active_not_recruiting NCT01738464
Microbiomes of Pelvic Pain No drug interventions Not Available Not Available completed NCT00534521
Posterior Tibial Nerve Stimulation vs. Sham No drug interventions Not Available 3 completed NCT01737684
A Single-Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Adults With Hepatic Insufficiency (MK-4618-013) treatment 1 completed NCT00171184
Efficacy, Safety, and Tolerability of Darifenacin in Patients Aged > 65 Years With Overactive Bladder treatment 4 completed NCT00536484
Fesoterodine Flexible Dose Study treatment 3 completed NCT05241379
AURA-2: Augmenting Urinary Reflex Activity No drug interventions treatment Not Available completed NCT02452879
Treatment, Parallel Assignment, Double Blind (Subject, Outcomes Assessor), Efficacy Study treatment Not Available unknown_status NCT05162833
Evaluation of the TheraNova Neuromodulation System to Provide Durable Relief of Overactive Bladder Symptoms No drug interventions treatment Not Available completed NCT02197533
Educating Patients on Management of Overactive Bladder: Written Versus Verbal Instructions No drug interventions treatment Not Available completed NCT04059133
The Effect of Low Intensity Extracorporeal Low Energy Shock Wave Therapy on Stress Urinary Incontinence and Overactivity Bladder No drug interventions treatment Not Available unknown_status NCT00168454
A Research Study for Patients With Overactive Bladder treatment 2 completed NCT00901251
Reproducibility Study of Over Active Bladder Symptom Score [OABSS] No drug interventions Not Available Not Available completed NCT00561951
Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder. treatment 2 completed NCT00863551
Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial treatment 4 completed NCT02677753
Percutaneous Nerve Evaluation With Fluoroscopy Versus Without No drug interventions treatment Not Available completed NCT00759577
Feasibility of "At-home" Titration of Solifenacin treatment 4 terminated NCT00321477
A Study Of GW679769 Compared To Placebo In Women With Overactive Bladder treatment 2 completed NCT00213577
NEUROTOX: Two Dosages of Type A Botulinic Toxin in Neurogenic Overactive Bladder No drug interventions treatment 2 terminated NCT06345677
Clinical Trial for the Assessment of Safety, Usability and Efficacy of the Vixe Combination for OAB in Female Subjects No drug interventions treatment Not Available completed NCT00876447
A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis treatment 3 completed NCT04120545
Effectiveness of Microcurrents Therapy in Overactive Bladder. No drug interventions treatment Not Available completed NCT00910845
Study of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence treatment 3 completed NCT04527445
Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement No drug interventions treatment Not Available recruiting NCT00921245
FREEDOM - First Real-Life Evaluation of Enablex Done in ZA Overactive Bladder Patients During a 3 Months Period Not Available Not Available completed NCT05256498
AURA 1: Augmenting Urinary Reflex Activity: Study 1 No drug interventions basic_science Not Available withdrawn NCT06529198
NeuroGyn Genital Neuromodulation System for iOAB Treatment No drug interventions treatment Not Available not_yet_recruiting NCT04570605
Feasibility of Parasacral Transcutaneous Electrical Nerve Stimulation PTENS for Voiding Dysfunction in Peds Population No drug interventions treatment Not Available completed NCT00578097
Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder treatment 2 terminated NCT01458197
A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo in Patients Suffering From Overactive Bladder. treatment 2 completed NCT01533597
The Efficacy of Solifenacin With or Without Tamsulosin in Adult Women With Overactive Bladder (OAB) treatment 4 completed NCT05910983
Prostate Enucleation With Intravesical Botox Injections in Treating BPH and Bladder Overactivity treatment Not Available not_yet_recruiting NCT05158361
Acupuncture for Overactive Bladder in Adults No drug interventions treatment Not Available recruiting NCT02980328
Low-level Light Therapy for Overactive Bladder and Urinary Incontinence No drug interventions treatment 3 unknown_status NCT00437528
Safety and Applicability Study of a Novel Heat Flow Sensor Unit for Measuring Urinary Bladder Capacity No drug interventions Not Available Not Available unknown_status NCT03727711
TPTNS: Home vs Hospital Treatment for Overactive Bladder No drug interventions treatment Not Available unknown_status NCT02916693
Mirabegron For Erectile Dysfunction treatment 1 / 2 completed NCT00691093
Study In Patients With Overactive Bladder Treated With Toviaz® After Failure Of Previous Therapy Not Available Not Available completed NCT01764893
Use of Percutaneous Tibial Nerve Stimulation With Solifenacin or Placebo to Treat Refractory Overactive Bladder No drug interventions treatment 4 terminated NCT06563193
Urinary Neurotrophin Levels as Potential Biomarkers for Overactive Bladder: A Case-Control Study No drug interventions Not Available Not Available enrolling_by_invitation NCT04155593
In-office Assessment of Voiding Function Following Botox Injection for Overactive Bladder No drug interventions Not Available Not Available completed NCT03662893
Behavioural Therapy With Checklist for Overactive Bladder No drug interventions treatment Not Available completed NCT04873271
Evaluation of Implantable Tibial Neuromodulation (TITAN 1) Feasibility Study No drug interventions device_feasibility Not Available completed NCT03087578
Comparison of Electroacupuncture to Mirabegron for Treatment of Overactive Bladder treatment Not Available withdrawn NCT05067478
Composur: Study to Understand the Performance of Vibegron in Participants With Overactive Bladder (OAB) Not Available Not Available active_not_recruiting NCT01488578
Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan) Not Available Not Available completed NCT02297178
A Follow-net Investigation of a Randomised Study of Cystoscopy and Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding No drug interventions Not Available Not Available withdrawn NCT00706407
Uro-NIRS Clinical Study No drug interventions diagnostic Not Available completed NCT04479709
The Urinary Microbiome in Patients Receiving Intradetrusor Botox Injections No drug interventions Not Available Not Available completed NCT01925456
Validation of Instruments for Pragmatic Clinical Trials for Overactive Bladder Not Available 1 completed NCT05240456
Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in Children treatment 1 / 2 unknown_status NCT02600715
Reduction of Bladder Injection Pain With Belladonna Opiate Suppository prevention 4 completed NCT02279615
Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia. treatment 4 unknown_status NCT01870037
Phase 1 Study With OAB Assessing the Safety and Activity of hMaxi-K Gene Transfer No drug interventions other 1 completed NCT04754737
Antibiotic Usage Prior to OnabotulinumtoxinA Injection No drug interventions prevention Not Available recruiting NCT00911937
A Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency treatment 4 completed NCT00780832
Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder No drug interventions treatment Not Available terminated NCT00773552
Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder treatment 4 withdrawn NCT02805452
Solifenacin Succinate for Treatment of Urinary Toxicity Occurring During Radiotherapy of Prostatic Cancer treatment 3 terminated NCT00425100
A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder Patients treatment 3 completed NCT02660359
Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2 treatment 3 terminated NCT01210859
Effects of Antimuscarinic Drugs on Overactive Bladder (OAB) Symptoms After Insertion of Ureteral Stents No drug interventions Not Available Not Available withdrawn NCT05844059
Lower Urinary Tract Symptoms After Intravesical Therapy No drug interventions Not Available Not Available recruiting NCT00871975
Tetra-NIRS Clinical Study No drug interventions diagnostic 4 terminated NCT02468375
Prospective Study for Patient Perception of Treatment Satisfaction After Switching to Mirabegron in Patients With Overactive Bladder Who Were Unsatisfied With Efficacy of Antimuscarinic Therapy or Adverse Event. treatment 4 completed NCT06110975
Deprescribing dRrugs for Overactive Bladder in General Practice (DROP) No drug interventions health_services_research Not Available enrolling_by_invitation NCT03451175
Reproductibility of Cystometry in Multiple Sclerosis Patient No drug interventions Not Available Not Available completed NCT06070675
Comparison of a Paper and Automated Bladder Diary in Pediatric Patients No drug interventions diagnostic Not Available recruiting NCT02389270
Urinary Neurotrophin Levels in Healthy Children No drug interventions Not Available Not Available unknown_status NCT00928070
A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder treatment 4 completed NCT01613170
Premarin Versus Toviaz for Treatment of Overactive Bladder treatment 4 unknown_status NCT03017170
Evaluation of the Effect of Dried Cranberry Powder in Women With Dry OAB No drug interventions supportive_care 1 completed NCT05485142
The Treatment Efficacy of Prolotherapy in Bladder Voiding Dysfunction No drug interventions treatment Not Available recruiting NCT02922842
A Study of Transcutaneous Electrical Nerve Stimulation for Overactive Bladder No drug interventions device_feasibility Not Available terminated NCT03371342
Treatment of MEDITOXIN® in Female Patients With Idiopathic Overactive Bladder treatment 1 completed NCT02735499
Instillation of Botox in the Bladder in Women With Overactive Bladder (OAB) treatment 2 completed NCT04578899
"The Effectiveness of Transvertebral Magnetic Neuromodulation in Patients With Detrusor Overactivity" No drug interventions treatment Not Available unknown_status NCT03742206
Comparison of Two Forms of Transcutaneous Electrical Stimulation in Overactive Bladder No drug interventions treatment Not Available unknown_status NCT01003249
Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen basic_science 4 terminated NCT04853849
Treatment of Overactive Bladder With a Digital Conversational Agent: the MOTIVATION Study No drug interventions Not Available Not Available unknown_status NCT05652036
Procedural Discomfort Related to Number of Intradetrusor Botox Injections treatment 4 recruiting NCT02704013
Urinary Biomarkers in Overactive Bladder in Children diagnostic Not Available unknown_status NCT00883818
Microorganism in Overactive Bladder Patients treatment 4 completed NCT03547518
Sham Controlled Trial of Rapid Induction Percutaneous Tibial Nerve Stimulation No drug interventions treatment Not Available completed NCT05099419
Repetitive Transcranial Magnetic Stimulation in Women With Overactive Bladder With Urgency Incontinence No drug interventions treatment 0 unknown_status NCT02040519
Time of Effect Onset in Treating Overactive Bladder or Non Obstructive Urinary Retention by Sacral Neuromodulation No drug interventions treatment Not Available completed NCT01767519
A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence treatment 3 completed NCT06181019
Acupuncture Combined With Mirabegron in the Treatment of OAB treatment 1 active_not_recruiting NCT06511141
Sacral Neuromodulation for Male Overactive Bladder (MOAB) No drug interventions treatment Not Available not_yet_recruiting NCT00431041
Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR) treatment 4 completed NCT01605617
Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate treatment 4 terminated NCT06184334
Management of OAB in Female Patients . treatment Not Available completed NCT05452434
Mirabegron Combined With Behavioral Intervention for Overactive Bladder：a Prospective Multicenter Randomized Controlled Clinical Study treatment 4 unknown_status NCT03946124
Fall Prevention in Older Adults With OAB treatment 4 completed NCT00313924
Assessing the OAB-8 Questionnaire as a Tool to Measure Treatment Outcome treatment 4 unknown_status NCT02715024
Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms treatment 4 completed NCT04957524
TEST-ON - Does iStim Reduce Urinary Urgency? No drug interventions treatment Not Available unknown_status NCT04016324
InterStim Basic Evaluation Lead Post-Market Clinical Follow-up Study No drug interventions treatment Not Available completed NCT01898624
Specified Drug Use-results Survey of Betanis Tablets Not Available Not Available completed NCT02129816
Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder No drug interventions treatment 2 / 3 terminated NCT05381116
A Sham-Controlled Study to Evaluate the Safety and Efficacy of a Smart, Self-Adjusting, Surgery-Free, Wearable Bladder Neuromodulation System for Overactive Bladder No drug interventions treatment Not Available terminated NCT01868516
Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder treatment 2 completed NCT00857896
Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years treatment 2 completed NCT00262496
Botulinum-A Toxin Injection for Detrusor Hyperreflexia in Spinal Cord Injury: A Non-Surgical Approach. treatment 2 withdrawn NCT00337558
A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR) treatment 4 completed NCT03057158
Genomics and Epigenomics for New Insights in fEmale OAB (GENIE) Study No drug interventions Not Available Not Available completed NCT03594058
A Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001) treatment 2 completed NCT02570035
Specified Drug Use-results Survey of Betanis Tablets for Patients With Coexisting Cardiovascular Disease Not Available Not Available completed NCT00290563
Safety and Efficacy of MK0594 to Treat Overactive Bladder (0594-003) treatment 2 completed NCT01122563
A Study to Evaluate Response of Overactive Bladder Symptom Score (OABSS) to Treatment Not Available Not Available completed NCT00343486
Dose Ranging Study Of Solabegron Versus Placebo In Female Patients With Overactive Bladder Symptoms treatment 2 completed NCT05226286
Evaluation of Implantable Tibial Neuromodulation Pivotal Study No drug interventions treatment Not Available active_not_recruiting NCT02670486
Audiovisual Stimulus During Urodynamics No drug interventions basic_science Not Available completed NCT02112786
Neuromodulation Implantation Settings Variation for Overactive Bladder No drug interventions treatment Not Available withdrawn NCT01367886
Comparative Urine Proteomic Studies of Overactive Bladder in Humans Not Available Not Available completed NCT03801239
Reliability of Polish-Version Overactive Bladder Syndrom Scores (OABSS) No drug interventions Not Available Not Available completed NCT05512039
Reduced-dose Botox for Urgency Incontinence Among Elder Females treatment 1 / 2 recruiting NCT04124939
Is 10 Injections of Bladder Botox Less Painful Than 20 Injections? treatment 4 completed NCT00594139
Autologous Neo-Bladder Construct in Non-Neurogenic Overactive Bladder and Urge Predominant Incontinence No drug interventions treatment 2 withdrawn NCT03213522
Comparison of Craniosacral Therapy vs Pelvic Floor Physical Therapy No drug interventions supportive_care Not Available unknown_status NCT05422625
PTNS for Female Patients Suffering From Multiple Sclerosis No drug interventions treatment Not Available recruiting NCT00444925
Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB) treatment 3 completed NCT04681625
Evaluation of Silodosin and Pelvic Floor Muscle Training in Men With Benign Prostatic Hyperplasia and Overactive Bladder No drug interventions treatment Not Available completed NCT06514430
Prophylactic Analgesia for Bladder Botox Injections treatment 4 not_yet_recruiting NCT02180048
"The Effects of Caffeine on Overactive Bladder Symptoms and Mental Health in Postmenopausal Women" No drug interventions supportive_care Not Available completed NCT00427648
Local Anesthetic Treatments for Overactive Bladder treatment 3 terminated NCT00786448
Post Marketing Surveillance Study on Emselex After Launch in Germany Not Available Not Available completed NCT01167257
Effects and Safety of Liposome Encapsulated Botulinum Toxin A for Overactive Bladder Syndrome treatment 2 completed NCT04999657
Evaluation of the The Neuromodulation System for the Treatment of Overactive Bladder Symptoms No drug interventions treatment Not Available completed NCT00611026
Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder. treatment 3 completed NCT00564226
SSR240600C Treatment in Women With Overactive Bladder treatment 2 completed NCT01127126
Bryophyllum Versus Placebo for Overactive Bladder treatment 2 completed NCT04506866
InterStim Micro Post Market Clinical Follow-up Study No drug interventions treatment Not Available terminated NCT01214265
A Clinical Study for Magnetic Stimulation of the Posterior Tibial Nerve in Overactive Bladder No drug interventions treatment Not Available completed NCT04470765
Transcutaneous Tibial Nerve Stimulation: the ZIDA Device Equivalence No drug interventions treatment Not Available completed NCT00910520
Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence treatment 3 completed NCT04547920
FREEOAB Study for Overactive Bladder No drug interventions treatment Not Available completed NCT02107820
Does Bladder Training Improve the Efficacy of Nerve Stimulation in Women With Refractory Overactive Bladders No drug interventions treatment Not Available completed NCT02614482
Extension Study of Fesoterodine for Overactive Bladder Syndrome in Children. treatment 3 completed NCT01175382
Combined Behavioral and Drug Treatment of Overactive Bladder in Men treatment 2 / 3 completed NCT04487431
A Trial to Learn How a New Liquid Form of BAY1817080 is Tolerated and Taken up by the Body of Healthy Male Participants (Part A). By Labeling BAY1817080 With a Radioactive Substance (Carbon 14) Researchers Want to Learn How the Study Drug is Processed and Excreted by the Body After Dosing (Part B) No drug interventions basic_science 1 completed NCT00131573
An Implantable Microstimulator for the Chronic Treatment of Urinary Urgency-Frequency Syndrome No drug interventions treatment 3 completed NCT02656173
A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH) treatment 4 completed NCT02536976
Mirabegron in Parkinson Disease and Impaired Cognition treatment 4 completed NCT04626960
ADRB3, ROCK2 and GEF Levels in Overactive Bladder Patients No drug interventions Not Available Not Available completed NCT03385460
Delivery of Intravesical Botulinum Toxin A Using Low Energy Shock Waves in Treatment of Overactive Bladder: A Feasibility Study No drug interventions treatment Not Available unknown_status NCT03061760
Effects of Urinary Bladder Hypertrophy on Urge Urine Incontinence After Radical Prostatectomy No drug interventions Not Available Not Available unknown_status NCT00465894
Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms treatment Not Available completed NCT03556891
Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary Incontinence No drug interventions treatment Not Available active_not_recruiting NCT06181591
A Trial Evaluating the Clinical Efficacy and Safety of Hibero SR (Mirabegron) 50 mg and Ditropan (Oxybutynin Chloride) 10 mg in Children Between 5 and 18 Years With Overactive Bladder (OAB) treatment 2 not_yet_recruiting NCT00231491
Efficacy and Safety of Botulinum Toxin A for the Treatment of Refractory Overactive Bladder. treatment 2 completed NCT03902080
Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) treatment 3 completed NCT02110680
Efficacy of Transcutaneous Nerve Stimulation on Improvement of Overactive Bladder Symptoms No drug interventions treatment 2 withdrawn NCT06387329
Bladder Botox UTI Antibiotic Prophylaxis prevention 4 recruiting NCT03175029
Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder. No drug interventions treatment 2 completed NCT02583529
Neurogenic Overactive Bladder Treatment on Parkinson's Disease Through Back Tibial Nerve Electrostimulation No drug interventions treatment 0 unknown_status NCT02495389
Mirabegron and Urinary Urgency Incontinence treatment 4 completed NCT03516292
Assessment of Potential Biomarkers in Women With Symptoms of Overactive Bladder and Pelvic Organ Prolapse No drug interventions Not Available Not Available unknown_status NCT00439192
ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder (OAB) treatment 2 terminated NCT03695692
Effects of Connective Tissue Massage in Women With Overactive Bladder No drug interventions treatment Not Available unknown_status NCT00461292
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder treatment 3 completed NCT05997992
Clinical Efficacy Evaluation of Electroacupuncture as Adjuvant Therapy for Female Patients With Overactive Bladder No drug interventions treatment Not Available recruiting NCT04423744
Study to Gather Information on the Influence of BAY1817080 on the Electrical Activity of the Heart Recorded by an Electrocardiogram in Healthy Male and Female Participants other 1 completed NCT05688644
Sacral Neuromodulation in Neurogenic Patients No drug interventions Not Available Not Available enrolling_by_invitation NCT03614767
Sacral Neuromodulation & Urodynamics No drug interventions Not Available Not Available unknown_status NCT02995967
Evaluation of Botulinum Toxin A Alone Versus Botulinum Toxin A With Hydrodistension for Treatment of Overactive Bladder treatment Not Available terminated NCT01302067
A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine treatment 4 completed NCT03888001
The Efficacy of Botulinum Toxin in OVERACTIVE Bladder No drug interventions Not Available Not Available unknown_status NCT02320201
Foot Neuromodulation for Overactive Bladder in Children No drug interventions other Not Available withdrawn NCT03136601
Percutaneous Tibial Nerve Stimulation Maintenance: Monthly Therapy or Per Patient Requested Need No drug interventions treatment Not Available unknown_status NCT01578304
Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive Bladder treatment 4 completed NCT04369404
Impact of Decision Aids in Urogynecology No drug interventions health_services_research Not Available completed NCT00943904
Comparison of Motor and Sensory Response With Interstim Stimulation No drug interventions health_services_research Not Available completed NCT01512004
Propiverine Hydrochloride Extended-Release Capsule for Overactive Bladder treatment 3 completed NCT02757768
A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) treatment 4 completed NCT01499069
Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients other Not Available completed NCT01739946
Urinary Biomarkers For Objective Measurement Of InterStim® Response In Over Active Bladder (OAB) Patients. No drug interventions Not Available Not Available completed NCT04534946
A Pilot Study Evaluating the Usability of the Oabi Mobile Application No drug interventions Not Available Not Available completed NCT02835846
Investigation of the Effect of the Female Urinary Microbiome on Incontinence treatment 4 completed NCT02821312
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of DA-8010 in Healthy Subjects No drug interventions treatment 1 unknown_status NCT01409512
Evaluation of Autonomic System Before and After Anticholinergic Treatment in Women With Overactive Bladder No drug interventions Not Available Not Available unknown_status NCT06206512
Effect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive Bladder treatment 2 recruiting NCT02620410
Treatment of REfractory Overactive BLadder With the AXonics Sacral Neuromodulation System (RELAX-OAB) No drug interventions treatment Not Available completed NCT05928910
Virtual Reality (VR) During Peripheral Nerve Evaluation (PNE) Procedure No drug interventions treatment Not Available withdrawn NCT00648310
Topical Oestrogens and Antimuscarinics In The Treatment Of Detrusor Overactivity Not Available 2 / 3 completed NCT00478881
A Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function treatment 2 completed NCT00746681
Investigation of Tolterodine, Pregabalin and a Tolterodine - Pregabalin Combination for the Treatment of Overactive Bladder treatment 2 completed NCT04265781
Study on the Safety of Drug BAY1817080 at Different Doses and the Way the Body Absorbs and Eliminates the Drug in Japanese Healthy Adult Male Participants No drug interventions basic_science 1 completed NCT00775281
Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC. No drug interventions Not Available Not Available completed NCT02865395
Timing of B and O Suppositories to Help Relieve Post-operative Bladder Spasms treatment 4 terminated NCT01050114
OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ER treatment 3 unknown_status NCT02622555
Cardiovascular Morbidity During Treatment of Overactive Bladder With B3 Agonists Not Available Not Available completed NCT02590250
A Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in India Not Available Not Available completed NCT00892450
Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease treatment Not Available completed NCT02315950
The Use of cineMRI to Evaluate Botox in Patients With Medication Refractory Overactive Bladder No drug interventions other Not Available recruiting NCT01122550
Reproducibility Study of Overactive Bladder Symptom Score [OABSS] No drug interventions Not Available Not Available completed NCT03106623
Study of ONO-8577 in Patients With Overactive Bladder treatment 2 completed NCT06484023
Posterior Tibial Transcutaneous Neurostimulation in Idiopathic Overactive Bladder No drug interventions Not Available Not Available completed NCT04357223
NOGO for an Overactive Bladder treatment 2 unknown_status NCT01955408
Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment No drug interventions Not Available Not Available completed NCT02660138
Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1 treatment 3 terminated NCT01302938
Web-based Methodology Trial to Evaluate the Efficacy and Safety of Tolterodine ER in Subjects With Overactive Bladder treatment 4 terminated NCT03199443
Standardization of Lead Placement for Sacral Neuromodulation Part 2 No drug interventions Not Available Not Available unknown_status NCT06250543
Evaluation of Intradetrusor AbobotulinumtoxinA and IncobotulinumtoxinA in Women With Overactive Bladder treatment 4 completed NCT03625843
Mindfulness Exercises to Reduce Anxiety and Pain During Urodynamic Testing No drug interventions treatment Not Available completed NCT03390790
Lidocaine for Pain After Urodynamic Testing treatment 4 completed NCT05672290
Comparison of the Effects of External Electrical Stimulation Protocols in Women With Overactive Bladder No drug interventions treatment Not Available not_yet_recruiting NCT00337090
A Study of YM178 in Patients With Symptomatic Overactive Bladder (DRAGON) treatment 2 completed NCT03687164
Group Medical Visits for Latina Women With Urgency Urinary Incontinence No drug interventions other Not Available terminated NCT00771264
Study of Urgent PC Versus Sham Effectiveness in Treatment of Overactive Bladder Symptoms No drug interventions treatment 4 completed NCT00876421
Study of ONO-8539 in Patients With Overactive Bladder treatment 2 completed NCT05393921
The Combined Effect of Intravesical Botox Injections and HoLEP Surgery in Treating Benign Prostatic Hyperplasia and Overactive Bladder treatment 4 not_yet_recruiting NCT00868621
Urinary Cytokines in Patients With Overactive Bladder (OAB) No drug interventions Not Available Not Available completed NCT03508921
Comparison of Methods for Prevention of Urinary Tract Infection Following Botox Injection prevention 4 terminated NCT00768521
A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107) treatment 1 completed NCT00902421
Efficacy and Safety of Selective Serotonin Reuptake Inhibitor (SSRI) in Overactive Bladder Patients treatment 4 completed NCT02361502
MIrabegron With oveRACtive bLadder Symptoms in mEn treatment 4 unknown_status NCT03575702
Efficacy and Safety Evaluating Study to Compare Uritos® (Imidafenacin) and Urotol® (Tolterodine) for Treatment of Overactive Bladder. treatment 3 completed NCT00658684
Long Term Study To Evaluate the Safety, Tolerability and Efficacy of Fesoterodine for Overactive Bladder. treatment 3 completed NCT00821184
Behavioral Modification and Vesicare Versus Vesicare Alone for Urge Incontinence in Patients With Overactive Bladder treatment 3 terminated NCT02526979
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB) basic_science 1 completed NCT05557279
Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 Weeks No drug interventions treatment 4 recruiting NCT02601287
A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean Patients treatment 4 completed NCT05685433
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE) No drug interventions treatment Not Available recruiting NCT02251054
Virtual Avatar Coaches for Behavioral Therapy of Patients With Overactive Bladder No drug interventions Not Available Not Available completed NCT03544554
Training and Counseling Program for Overactive Bladder Treatment No drug interventions treatment Not Available completed NCT03655054
eCoin for OAB Feasibility Follow-on Study No drug interventions treatment Not Available completed NCT06489951
Efficacy and Safety of Vitamin D Supplementation Combined With Standard Behavioral Therapy in the Treatment of OAB-dry in Children treatment Not Available not_yet_recruiting NCT01089751
Efficacy of Sanctura XR (Trospium Chloride) for Reducing Overactive Bladder Symptoms in Female Subjects Refractory to Detrol LA (Tolterodine Tartrate Extended Release) Daily treatment 4 completed NCT02335853
Association Between Metabolic Syndrome and Serum Nerve Growth Factor Levels in Women With Overactive Bladder No drug interventions Not Available Not Available unknown_status NCT00495053
Safety Study of hMaxi-K Gene Transfer to Treat Overactive Bladder and Detrusor Overactivity No drug interventions treatment 1 terminated NCT01747577
Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate) treatment 4 completed NCT01642277
Bacterial Genomic Sequencing in Overactive Bladder diagnostic 2 completed NCT05672277
Comparison of the Effects of Transcutaneous Electrical Nerve Stimulation Protocols in Women With Overactive Bladder No drug interventions treatment Not Available not_yet_recruiting NCT04758247
Evaluation of the TheraNova Neuromodulation System for the Treatment of Overactive Bladder Symptoms No drug interventions treatment Not Available completed NCT01919047
Drug Use-Results Survey of Betanis Tablets in Japan Not Available Not Available completed NCT00862745
Bringing Simple Urge Incontinence Diagnosis & Treatment to Providers (BRIDGES) treatment 4 completed NCT00903045
Urinary Urgency Outcomes Following Propiverine Treatment for an Overactive Bladder treatment 4 completed NCT01187498
Behavioral Treatment of Overactive Bladder in Men treatment 3 completed NCT00879398
Toviaz Post Marketing Surveillance Study Not Available Not Available completed NCT00174798
MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence. treatment 2 completed NCT02540798
Do Patient Anxiety Levels Decrease Urodynamic Test Reproducibility? No drug interventions Not Available Not Available completed NCT05903105
Diversity in Patients With OAB No drug interventions Not Available Not Available not_yet_recruiting NCT01003405
Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder treatment 3 withdrawn NCT02180997
Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin treatment 1 completed NCT01972061
Foot/Hand Neuromodulation for Overactive Bladder (OAB) No drug interventions treatment Not Available terminated NCT01569061
Painless Laser Therapy for Overactive Bladder No drug interventions treatment Not Available unknown_status NCT00441428
Safety And Efficacy Of Solifenacin In Men With Overactive Bladder (OAB) And Detrusor Underactivity Not Available Not Available completed NCT04865328
Impact of OAB Symptoms on Quality of Life in Croatia No drug interventions Not Available Not Available unknown_status NCT04115228
Clinical Feasibility Study, Implantable Tibial Nerve Stimulator (ITNS) No drug interventions device_feasibility Not Available completed NCT00481728
Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate. other 1 completed NCT00793611
Hypnotherapy for Treatment of Overactive Bladder No drug interventions treatment Not Available completed NCT04791111
AQUA: Anticholinergic Side Effects QUestionnAire No drug interventions Not Available Not Available completed NCT05576311
Codesign of an Optical Device to Measure Urine Flow and Volume No drug interventions Not Available Not Available not_yet_recruiting NCT05013593
Red Clover Isoflavones in Postmenopausal Women With Urge Urinary Incontinence and Overactive Bladder No drug interventions basic_science Not Available completed NCT04448171
TENS Used for Pain Management During Office Cystoscopy Botox Injections No drug interventions treatment Not Available recruiting NCT01189071
Preoperative Use of Darifenacin (Enablex) to Alleviate Postoperative Ureteral Stent Pain treatment Not Available terminated NCT02398578
Cystoscopic Ablation Via RF Energy Clinical Trial No drug interventions other 1 / 2 terminated NCT00547378
InSite for Over Active Bladder No drug interventions treatment 4 completed NCT03156088
Clinical and Urodynamic Predictors for Sacral Neuromodulation Outcomes in Overactive Bladder No drug interventions Not Available Not Available unknown_status NCT02271607
The Effect and Safety of Moxibustion Therapy for Overactive Bladder Patients No drug interventions treatment Not Available completed NCT03904407
Optimizing Overactive Bladder Treatment No drug interventions treatment Not Available completed NCT02786407
A Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A in Patients With Overactive Bladder (OAB) treatment 3 unknown_status NCT01539707
Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder other 1 completed NCT02790307
Transcutaneous Tibial Nerve Stimulation of Patients With Overactive Bladder (OAB) Syndrome No drug interventions treatment 2 completed NCT03260907
Efficacy and Safety of Electroacupuncture and Acupuncture in Postmenopausal Women With Overactive Bladder No drug interventions treatment Not Available unknown_status NCT01657409
Different Injection Number of the Same Dose of Botulinum Toxin A on Overactive Bladder Syndrome treatment 2 completed NCT01489709
Post Marketing Survey of Vesicare in Japan Not Available Not Available completed NCT01644409
Urgent-SQ in Treatment of Overactive Bladder Syndrome: 9-yr Follow up No drug interventions Not Available Not Available completed NCT03149809
Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease treatment 3 completed NCT04950556
The Effects of Pelvic Floor Muscle Training in Women With Overactive Bladdder No drug interventions treatment Not Available unknown_status NCT06458556
Transvaginal Radiofrequency Ablation for Overactive Bladder No drug interventions treatment Not Available completed NCT01842685
Bladder Thermal Distention for Patients With Refractory Overactive Bladder No drug interventions treatment Not Available unknown_status NCT04485585
A Study to Evaluate Drug-drug Interactions Between BR9006-1 and BR9006-2 in Healthy Male Volunteers. treatment 1 completed NCT01369485
Safety and Effectiveness of a Non-invasive Neuromodulation Device on Urgency Urinary Incontinence in Overactive Bladder No drug interventions treatment Not Available completed NCT00512785
Long-term Safety and Efficacy of Imidafenacin in Patients With Overactive Bladder treatment 3 completed NCT03595215
Posterior Tibial Nerve Stimulation's Effectiveness in UI Frequency in Overactive Patients in Home No drug interventions treatment Not Available completed NCT01004315
A Confirmatory Study of KUC-7483 in Patients With Overactive Bladder treatment 3 completed NCT04917315
To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive Bladder No drug interventions treatment 3 completed NCT01130415
Screening Method in Sacral Neuromodulation No drug interventions Not Available Not Available completed NCT04471337
Study on the Safety of BAY1817080 How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given to Participants With Moderate Renal Impairment and End Stage Renal Disease Requiring Dialysis Compared With Matched Participants With Normal Renal Function No drug interventions basic_science 1 completed NCT05772637
Clinical and Urodynamic Assessment of Bladder Sensation in Multiple Sclerosis No drug interventions diagnostic Not Available recruiting NCT03829137
The Clinical Effects of Laser Acupuncture Therapy for OAB Women. No drug interventions treatment Not Available unknown_status NCT00212732
Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan treatment 3 completed NCT04907032
Posterior Tibial Nerve Stimulation (PTNS) Plus Mirabegron to Treat Refractory OAB Symptoms (PTNS-M Study) treatment 4 completed NCT04063852
PTNS on Urinary and Global Quality of Life in MS Patients No drug interventions Not Available Not Available completed NCT00189800
A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder treatment 3 completed NCT05170100
Evaluating a Digital Intervention for Overactive Bladder No drug interventions treatment Not Available completed NCT02240459
A Study of Fesoterodine and Oxybutynin on Cognitive Function in Mild Cognitive Impairment other 2 completed NCT05557175
Repetitive Transcranial Magnetic Stimulation (rTMS) on Neurogenic Overactive Bladder in Stroke No drug interventions treatment Not Available completed NCT00448175
Overactive Bladder Innovative Therapy Trial (OrBIT) treatment 4 completed NCT02476175
Add-on Mirabegron in Pediatric Patients With Refractory Overactive Bladder treatment 3 completed NCT00856570
A Clinical Study to Determine the Effect of YM178 on the Pharmacokinetics of Warfarin in Healthy Subjects basic_science 1 completed NCT02143570
Efficacy of Darifenacin and Physiotherapy for the Treatment of Overactive Bladder in Women treatment 3 completed NCT02667470
Reproducibility Study of OABSS and Its Response to Treatment treatment 4 completed NCT01437670
Observational Study to Estimate the Dry Mouth in OAB Patients With Solifenacin Not Available Not Available completed NCT06569342
Botulinum Neurotoxin Type A (BoNT-A) in Paediatric Non-neurogenic Therapy Resistant Overactive Bladder (OAB) No drug interventions Not Available Not Available completed NCT02070042
Oxybutynin and Omega-3 for OAB (Overactive Bladder) treatment Not Available terminated NCT04186442
Evaluate the Safety and Efficacy of Botulax® Versus Botox® in Patient With Overactive Bladder treatment 1 completed NCT01628042
A Single Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Participants With Renal Insufficiency (MK-4618-014) treatment 1 completed NCT06437899
Evaluation of Efficacy and Patient Satisfaction of Local Anaesthesia Versus Sedoanalgesia for Botox (R) Injection in the Urinary Bladder for the Treatment of Idiopathic Overactive Bladder treatment Not Available enrolling_by_invitation NCT02179099
Safety and Efficacy of Intravesical Botulinum Toxin in TC-3 Gel in OAB Patients No drug interventions treatment 1 / 2 terminated NCT00922506
Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH) treatment 4 completed NCT00212706
Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan treatment 2 completed NCT03475706
Evaluation of the Efficacy and Safety of Solabegron Tablets for Treatment of Overactive Bladder in Adult Women treatment 2 completed NCT02494349
The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers. treatment 1 completed NCT02522936
Use of Biotene Moisturizing Mouth Spray for Xerostomia Associated With Oral Oxybutynin Use treatment 4 withdrawn NCT00350636
A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo treatment 3 completed NCT02327936
Fesoterodine and Oxybutynin XL for Overactive Bladder Syndrome in Children treatment 3 completed NCT00685113
A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder treatment 3 completed NCT05799313
Home Versus Office Removal of Percutaneous Nerve Evaluation (PNE) Lead No drug interventions treatment Not Available recruiting NCT05337813
Effects of Low-intensity Excoporeal Shock Wave Therapy (LiESWT) on Women With Pelvic Floor Dysfunction No drug interventions treatment Not Available unknown_status NCT03412513
Mirabegron for Treatment of Overactive Bladder Symptoms in Patients With Parkinson's Disease treatment 4 unknown_status NCT05117918
Overactive Bladder Telemedicine Non-inferiority Trial No drug interventions other Not Available completed NCT01729819
Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women treatment 2 completed NCT00583219
Botulin-A Toxin Instillations and Overactive Bladder treatment 1 / 2 completed NCT00332319
Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients treatment 2 terminated NCT05783219
Lidocaine Patches Prior to Percutaneous Nerve Evaluation treatment 2 completed NCT03558919
Efficacy and Safety of the Mirabegron Compared With Solifenacin in Treatment of Overactive Bladder treatment 4 completed NCT04113941
Clinical Trial to Evaluate the Efficacy and Safety of MEDITOXIN® in Subject With Idiopathic Overactive Bladder No drug interventions treatment 3 unknown_status NCT05677841
Effects of Spinal Stabilization Exercises Focusing on the Pelvic Floor in Women With Overactive Bladder No drug interventions treatment Not Available completed NCT03023241
Diagnosis of Bladder Pain Syndrome / Interstitial Cystitis No drug interventions diagnostic Not Available completed NCT06483217
Optimal Injection Interval for Intra-Detrusor Botulinum Toxin No drug interventions treatment Not Available not_yet_recruiting NCT02511717
A Trial of Transcutaneous Nerve Stimulation for OAB No drug interventions treatment Not Available completed NCT05330117
Nerve Stimulation Using a TENS to Provide Pain Relief During Surgery for Overactive Bladder No drug interventions treatment Not Available completed NCT02852317
Urinary Markers of Detrusor Overactivity in Spina Bifida Patients No drug interventions Not Available Not Available completed NCT01093534
Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder. basic_science 4 completed NCT03566134
A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder treatment 2 completed NCT04454424
Study on the Safety of BAY1817080, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug in Participants With Impaired Liver Function or Normal Liver Function basic_science 1 completed NCT00575016
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder treatment 2 terminated NCT03280316
Efficacy Comparison Between Different Management Strategies for Consistent OAB in Patients With SVMs After Surgery treatment Not Available unknown_status NCT02857816
PRospective Study to Evaluate EffectivenesS With the NURO™ PErcutaneous Tibial Neuromodulation System in Patients With OAB No drug interventions treatment Not Available completed NCT00427596
A Two-Part Study to Determine: Best Medication Formulation and Food Effect treatment 1 completed NCT00479596
This is a Prospective, Randomized, Double-Blind Study Comparing Intravesical Injection of Botox® to Placebo. treatment 2 / 3 unknown_status NCT00852696
Over Active Bladder Patients Having Sling Surgery treatment Not Available terminated NCT02086058
Gene Expression in the Overactive Bladder in Children No drug interventions Not Available Not Available unknown_status NCT00943735
This Is An Open-Label Study To Evaluate Fesoterodine Plus "Your Way" Patient Support Plan In Patients With Symptoms Of Overactive Bladder Not Available Not Available completed NCT00730535
Exploring Predictors of Symptoms Relapse After Discontinuation of Treatment in Overactive Bladder (OAB) Patients treatment 4 completed NCT01833663
Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal Women treatment 4 completed NCT01540786
An Exploratory Study to Investigate Bladder Contractions in the Storage Phase and Related Bladder Sensations in Healthy Females and Females With Overactive Bladder (OAB) Using High Resolution and Conventional Urodynamics No drug interventions health_services_research 1 terminated NCT01515722
Interventions to Enhance Medication Persistence and Compliance in Patients With Overactive Bladder No drug interventions treatment Not Available completed NCT00932022
Trospium Chloride XR in Obese Female Patients With Overactive Bladder treatment 4 completed NCT01125722
Clinical Trial to Study a Non-invasive Neurostimulation Device on Urgency (Urinary) Incontinence Overactive Bladder (OAB) No drug interventions treatment Not Available completed NCT03194425
Standardization of Lead Placement for Sacral Neuromodulation. Part 1 No drug interventions diagnostic Not Available unknown_status NCT00915525
Long Term Follow-up Study of Safety and Efficacy of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence treatment 3 completed NCT04068025
Information, Motivation, Behavioral Skills Model on Urinary Incontinence and Quality of Life in Men No drug interventions other Not Available completed NCT00795925
Dose-Escalating Study of Propiverine Hydrochloride in Children Suffering From Overactive Bladder Not Available 2 completed NCT02468830
Pilot Study of Mirabegron in Pediatric Patients With Overactive Bladder treatment 3 completed NCT01758848
Physical Therapy for Overactive Bladder No drug interventions Not Available Not Available terminated NCT03923348
Pelvic Floor Muscle Training With Leva System for Urge Incontinence No drug interventions treatment Not Available terminated NCT02657057
Effects of Transcutaneous and Percutaneous PTNS on Idiopathic OAB No drug interventions treatment Not Available completed NCT00553657
The Study To Test The Effect of Standardization Of Fluid Intake In Female Patients With Overactive Bladder diagnostic 1 completed NCT01220726
Botox for the Treatment of Overactive Bladder Secondary to Benign Prostatic Obstruction treatment 3 completed NCT06059066
Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction No drug interventions treatment Not Available recruiting NCT01848366
Utilization of the BIOWAVE Device to Treat Overactive Bladder No drug interventions treatment Not Available completed NCT05415865
The Effect of Local Anesthetic Solution in the Bladder Prior to Botox Injections in the Bladder supportive_care 3 unknown_status NCT04477265
Efficacy of Biofeedback PFMT and Medication in Women With Overactive Bladder treatment Not Available completed NCT02377765
Use of Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS) in Maintaining OAB Symptoms Improvement. No drug interventions treatment Not Available completed NCT02568774
Acupuncture on Post-Stroke Overactive Bladder No drug interventions treatment Not Available completed NCT01933074
Clinical and Biochemical Evidence of Neurogenic Inflammation in Women With Urinary Urgency No drug interventions Not Available Not Available completed NCT01824420
Flexibly adding-on Second Antimuscarinic Agent to the First Antimuscarinics for Refractory Overactive Bladder Syndrome treatment 4 completed NCT01901120
Long-Term Specified Drug Use-results Survey of Betanis Tablets Not Available Not Available completed NCT06226220
Percutaneous Nerve Evaluation Trial Time No drug interventions treatment Not Available recruiting NCT03473782
Overactive Bladder (OAB) Voiding Diary and Urodynamics Correlation Study No drug interventions Not Available Not Available completed NCT01294982
Study of AOBO-001 for Overactive Bladder With Urge Urinary Incontinence and Frequency No drug interventions treatment 2 completed NCT01187082
Grouptraining for Overactive Bladder in Adults No drug interventions health_services_research Not Available completed NCT02202031
Controlling Urgency Through Relaxation Exercises No drug interventions treatment Not Available completed NCT03817931
Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder prevention 4 completed NCT01178827
Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART-II) Trial treatment 4 completed NCT00311376
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder treatment 3 completed NCT04429360
What is the Effect of Prolapse Surgery on Voiding? No drug interventions Not Available Not Available unknown_status NCT00754260
Caffeine Reduction and Overactive Bladder Symptoms No drug interventions treatment Not Available terminated NCT02396160
The Effect of Urox™ in the Treatment of Overactive Bladder and Urinary Incontinence No drug interventions treatment Not Available completed NCT00771394
Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia treatment 4 completed NCT03019094
Overactive Bladder Posterior Tibial Implantable MIcro STimulator - 1 No drug interventions treatment Not Available withdrawn NCT01745094
A Study to Evaluate the Effect of Mirabegron + Solifenacin in Overactive Bladder Patients treatment 4 completed NCT04534491
Study to Gather Information About the Actual Use of an Adhesive Patch Placed on the Skin to Deliver Oxytrol Through the Skin Into the Bloodstream. treatment 3 completed NCT03874780
Vibe First In Human Study for the Assessment of Safety and Initial Performance of the Vibe Delivery System in Subjects With Idiopathic Overactive Bladder No drug interventions treatment Not Available completed NCT06347380
Usability Study of the FemPulse System No drug interventions treatment Not Available recruiting NCT04545580
Clinical Study to Evaluate the Treatment Effect and Safety of BAY1817080 in Patients With Overactive Bladder (OAB) No drug interventions treatment 2 completed NCT03643380
Acute Study to Evaluate a Novel Implantable Midfield Powered Device in Humans With Urinary Incontinence No drug interventions device_feasibility 1 completed NCT00238680
Programmable Timer in the Bladder Rehabilitation Treatment of OAB No drug interventions treatment Not Available completed NCT00220389
Two Phase Extension Trial of SP668 to Investigate the Safety and Tolerability of Sustained Release Fesoterodine in Subjects With Overactive Bladder: a Double-Blind Phase Followed by an Open-Label Extension Phase Not Available 2 completed NCT03080389
Sensitivity of Extended Cultures in Diagnosing Urinary Tract Infections No drug interventions Not Available Not Available terminated NCT05464589
Effects of Transcutaneous Tibial Nerve Stimulation for Overactive Bladder Symptoms in Adults No drug interventions treatment Not Available completed NCT01945489
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder treatment 4 completed NCT05362292
TReating Incontinence for Underlying Mental and Physical Health treatment 4 recruiting NCT00714792
Pilot Study: Is Overactive Bladder Caused by Subacute Urinary Tract Infections? No drug interventions Not Available Not Available completed NCT00439140
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder treatment 3 terminated NCT00501267
A Study To Test The Interaction of Two Medications for Treatment of Overactive Bladder treatment 1 completed NCT05494567
Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB treatment 4 unknown_status NCT01940367
Electrical Nerve Stimulation for Overactive Bladder a Comparison of Treatments No drug interventions treatment Not Available unknown_status NCT02447367
Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers No drug interventions treatment 1 completed NCT02485067
Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB treatment 3 completed NCT04734301
Intravaginal Electrical Stimulation With Different Treatment Frequency in Women With Idiopathic Overactive Bladder No drug interventions treatment Not Available completed NCT04831801
OAB and the Microbiome No drug interventions Not Available Not Available terminated NCT03104101
Transcutaneous Posterior Tibial Nerve Electrostimulation With Low Dose Trospium Chloride in OAB in Females No drug interventions other Not Available completed NCT00884104
A Study to Evaluate Add on Effect of Solifenacin in Men With Overactive Bladder Symptoms After Tamsulosin Monotherapy for 4 Weeks treatment 4 completed NCT03583372
An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB). treatment 3 completed NCT05282069
A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive Bladder treatment 3 completed NCT02674269
Safety and Efficacy Study of Intravesical Instillations of BotuGelTM, Slow Release RTGel Based Botox® Formulations, in Idiopathic OAB Patients With Urinary Incontinence ("INTIMO2") No drug interventions treatment 1 / 2 withdrawn NCT00782769
A Safety Extension Study of DR-OXY-301 treatment 3 completed NCT02524769
The Estrogen Impact on Overactive Bladder Syndrome: Female Pelvic Floor Microbiomes and Antimicrobial Peptides treatment Not Available completed NCT02211846
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive Bladder basic_science 1 completed NCT03500146
Sexual Function Trial of Overactive Bladder: Medication Versus PTNS No drug interventions Not Available Not Available completed NCT01047046
Combined Anticholinergic Medication and Sacral Neuromodulation to Treat Refractory Overactive Bladder No drug interventions Not Available Not Available completed NCT00224146
Transdermal (TDS) Oxybutynin (Oxytrol(r)) in Overactive Bladder treatment 4 completed NCT02873312
Overactive Bladder Treatment Using StimRouter Neuromodulation System: A Prospective Randomized Trial No drug interventions treatment Not Available unknown_status NCT04020510
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder treatment 4 recruiting NCT01768910
Supraspinal Control of Lower Urinary Tract Function in Healthy Controls and Patients With Bladder Dysfunction No drug interventions basic_science Not Available completed NCT05087810
Stress and Anxiety Effects on Overactive Bladder No drug interventions Not Available Not Available terminated NCT01314781
Therapy of the Overactive Bladder Syndrome treatment 4 completed NCT00836381
Assessment of Patient-reported Goal Attainment in the Treatment of Female Overactive Bladder treatment 4 completed NCT03492281
A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) treatment 3 completed NCT01663181
Pain-perception During Outpatient cystoscopy-a Prospective Controlled Study No drug interventions Not Available Not Available completed NCT00667095
Over Active Bladder Instillation Study - Botox treatment 3 terminated NCT02940314
Safety and Pharmacokinetic Characteristics After Administration of HIP1503 and HGP1103 in Healthy Male Volunteers treatment 1 completed NCT04031014
High Intensity Focused Electromagnetic Field Device for Urinary Incontinence No drug interventions treatment Not Available recruiting NCT03477214
Tactile Imaging and Electromyography No drug interventions Not Available Not Available completed NCT04910555
Strong Desire to Void and Balance in Older Women With Overactive Bladder No drug interventions Not Available Not Available completed NCT03753750
Noninvasive Spinal Cord Stimulation for Neurogenic and Idiopathic Overactive Bladder No drug interventions treatment Not Available withdrawn NCT04103450
Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia treatment 3 completed NCT05200923
Pelvic Health Electrically Evoked Recording (PEER) 2 Study No drug interventions device_feasibility Not Available recruiting NCT00138723
Trial to Investigate the Efficacy, Tolerability and Safety of Fesoterodine Sustained Release in Subjects With Overactive Bladder Syndrome Not Available 3 completed NCT05652023
Noninvasive Ultrasound Assessment of Detrusor Dysfunction No drug interventions Not Available Not Available recruiting NCT04437108
Efficacy of Li-SWT on Persistent Storage Symptoms After Transurethral Surgery for BPO treatment Not Available completed NCT01166438
Anticholinergic vs. Botox Comparison Study treatment 3 completed NCT04364438
Effectiveness of EMS and TENS in Patients With Overactive Bladder No drug interventions treatment Not Available unknown_status NCT04619238
Reliability of KHQ and ICIQ-SF in Assessing Urinary Incontinence Effects in Polish Women No drug interventions Not Available Not Available completed NCT02502838
The Effect of an Additional Stress Incontinence Procedure on Overactive Bladder During Pelvic Organ Prolapse Repair No drug interventions Not Available Not Available completed NCT01423838
Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder treatment 4 unknown_status NCT05997043
Safety and Efficacy of Botulinum Toxin A for Treatment of Overactive Bladder in Parkinson's Disease No drug interventions treatment 0 recruiting NCT00603343
Propiverine in Children Suffering From Non-Neurogenic Overactive Bladder and Urinary Incontinence treatment 3 completed NCT02186041
Sacral Neuromodulation With InterStim® Therapy for Intractable Urinary Voiding Dysfunctions (SOUNDS): an Observational Study No drug interventions Not Available Not Available completed NCT02299544
BlueWind Medical System for the Treatment of Patients With OAB No drug interventions treatment Not Available completed NCT01672190
Lessening Incontinence by Learning Yoga No drug interventions treatment Not Available completed NCT01260311
Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder Not Available Not Available completed NCT01318837
A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin Treatment Not Available 4 completed